Literature DB >> 16495721

The Experiential Discounting Task is sensitive to cigarette-smoking status and correlates with a measure of delay discounting.

Brady Reynolds1.   

Abstract

This research compared three different measures of discounting in adult cigarette smokers (n=15; consumed >or=20 cigarettes per day) and nonsmokers (n=15; self-reported never smokers). Participants completed the Experiential Discounting Task (EDT) and question-based measures of delay and probability discounting. The Experiential Discounting Task is a new real-time choice procedure purported to assess delay discounting. The Experiential Discounting Task provides choice consequences (i.e. delays, probabilities, and monetary rewards delivered from a coin dispenser) during choice sessions, whereas the question-based measures are hypothetical (i.e. delays, probabilities, and rewards are not directly experienced). Smokers discounted more than nonsmokers on all three measures. Additionally, the Experiential Discounting Task was significantly correlated with the question-based measure of delay discounting but not probability discounting. These results suggest all three discounting procedures are sensitive to cigarette-smoking status among adult smokers and nonsmokers and that the Experiential Discounting Task may be more comparable to measures of delay discounting than probability discounting.

Entities:  

Mesh:

Year:  2006        PMID: 16495721     DOI: 10.1097/01.fbp.0000190684.77360.c0

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  30 in total

1.  DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls.

Authors:  Yannis Paloyelis; Philip Asherson; Mitul A Mehta; Stephen V Faraone; Jonna Kuntsi
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

2.  Delay discounting predicts cigarette smoking in a laboratory model of abstinence reinforcement.

Authors:  Jesse Dallery; Bethany R Raiff
Journal:  Psychopharmacology (Berl)       Date:  2007-01-05       Impact factor: 4.530

3.  Individual differences in discount rate are associated with demand for self-administered cocaine, but not sucrose.

Authors:  Mikhail N Koffarnus; James H Woods
Journal:  Addict Biol       Date:  2011-08-04       Impact factor: 4.280

4.  Delay discounting decreases in those completing treatment for opioid dependence.

Authors:  Reid D Landes; Darren R Christensen; Warren K Bickel
Journal:  Exp Clin Psychopharmacol       Date:  2012-02-27       Impact factor: 3.157

5.  Test-retest reliability and construct validity of the Experiential Discounting Task.

Authors:  Rochelle R Smits; Jeffrey S Stein; Patrick S Johnson; Amy L Odum; Gregory J Madden
Journal:  Exp Clin Psychopharmacol       Date:  2013-02-18       Impact factor: 3.157

6.  Delay discounting in adults receiving treatment for marijuana dependence.

Authors:  Erica N Peters; Nancy M Petry; Donna M Lapaglia; Brady Reynolds; Kathleen M Carroll
Journal:  Exp Clin Psychopharmacol       Date:  2012-12-17       Impact factor: 3.157

Review 7.  Quantifying reinforcement value and demand for psychoactive substances in humans.

Authors:  Adrienne J Heinz; Todd C Lilje; Jon D Kassel; Harriet de Wit
Journal:  Curr Drug Abuse Rev       Date:  2012-12

8.  Impulsive choice and response in dopamine agonist-related impulse control behaviors.

Authors:  Valerie Voon; Brady Reynolds; Christina Brezing; Cecile Gallea; Meliha Skaljic; Vindhya Ekanayake; Hubert Fernandez; Marc N Potenza; Raymond J Dolan; Mark Hallett
Journal:  Psychopharmacology (Berl)       Date:  2009-10-20       Impact factor: 4.530

9.  Disinhibitory psychopathology and delay discounting in alcohol dependence: personality and cognitive correlates.

Authors:  Lyuba Bobova; Peter R Finn; Martin E Rickert; Jesolyn Lucas
Journal:  Exp Clin Psychopharmacol       Date:  2009-02       Impact factor: 3.157

10.  Subtyping patients with heroin addiction at treatment entry: factor derived from the Self-Report Symptom Inventory (SCL-90).

Authors:  Icro Maremmani; Pier Paolo Pani; Matteo Pacini; Jacopo V Bizzarri; Emanuela Trogu; Angelo Gi Maremmani; Gilberto Gerra; Giulio Perugi; Liliana Dell'Osso
Journal:  Ann Gen Psychiatry       Date:  2010-04-13       Impact factor: 3.455

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.